Medicines update

The US Food and Drug Administration advisory committee has decided against recommending a label change for naproxen containing medicines, while Australian researchers have discovered a potentially life-saving clot-busting drug, in the latest medicines update.

No label change for Naproxen

Findings from a meta analysis showing that naproxen may have a lower risk of cardiovascular thrombotic events has not persuaded the US Food and Drug Administration (FDA) advisory committee to recommend changing the drug's label.

The panel met yesterday (Tuesday 11 February

Latest

Trending